Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Virus-cell and cell-cell fusion mediated by the HIV-1 envelope glycoprotein is inhibited by short gp41 N-terminal membrane-anchored peptides lacking the critical pocket domain
  2. Wexler-Cohen, Y.; Ashkenazi, A.; Viard, M.; Blumenthal, R.; Shai, Y.
  3. Faseb Journal. 2010, Nov; 24(11): 4196-4202.
  1. 2.   Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion
  2. Finnegan, C. M.; Rawat, S. S.; Cho, E. H.; Guiffre, D. L.; Lockett, S.; Merrill, A. H.; Blumenthal, R.
  3. Journal of Virology. 2007, May; 81(10): 5294-5304.
  1. 3.   Sphingolipids, cholesterol, and HIV-1: A paradigm in viral fusion
  2. Rawat, S. S.; Viard, M.; Gallo, S. A.; Blumenthal, R.; Puri, A.
  3. Glycoconjugate Journal. 2006, MAY; 23(3-4): 189-197.
  1. 4.   Sphingolipids: Modulators of HIV-1 infection and pathogenesis
  2. Rawat, S. S.; Johnson, B. T.; Puri, A.
  3. Bioscience Reports. 2005, OCT; 25(5-6): 329-343.
  1. 5.   Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A
  2. Witvrouw, M.; Fikkert, V.; Hantson, A.; Pannecouque, C.; O'Keefe, B. R.; McMahon, J.; Stamatatos, L.; De Clercq, E.; Bolmstedt, A.
  3. Journal of Virology. 2005, JUN; 79(12): 7777-7784.
  1. 6.   Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4
  2. Yang, Q. E.; Stephen, A. G.; Adelsberger, J. W.; Roberts, P. E.; Zhu, W. M.; Currens, M. J.; Feng, Y. X.; Crise, B. J.; Gorelick, R. J.; Rein, A. R.; Fisher, R. J.; Shoemaker, R. H.; Sei, S.
  3. Journal of Virology. 2005, MAY; 79(10): 6122-6133.
  1. 7.   Mechanisms of nonrandom human immunodeficiency virus type 1 infection and double infection: Preference in virus entry is important but is not the sole factor
  2. Chen, J. B.; Dang, Q.; Unutmaz, D.; Pathak, V. K.; Maldarelli, F.; Powell, D.; Hu, W. S.
  3. Journal of Virology. 2005 79(7): 4140-4149.
  1. 8.   TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells
  2. Herbeuval, J. P.; Boasso, A.; Grivel, J. C.; Hardy, A. W.; Anderson, S. A.; Dolan, M. J.; Chougnet, C.; Lifson, J. D.; Shearer, G. M.
  3. Blood. 2005 105(6): 2458-2464.
  1. 9.   Marked structural and functional heterogeneity in CXCR4: Separation of HIV-1 and SDF-I alpha responses
  2. Sloane, A. J.; Raso, V.; Dimitrov, D. S.; Xiao, X. D.; Deo, S.; Muljadi, N.; Restuccia, D.; Turville, S.; Kearney, C.; Broder, C. C.; Zoellner, H.; Cunningham, A. L.; Bendall, L.; Lynch, G. W.
  3. Immunology and Cell Biology. 2005 83(2): 129-143.
  1. 10.   An inhibitor of glycosphingolipid metabolism blocks HIV-1 infection of primary T-cells
  2. Puri, A.; Rawat, S. S.; Lin, H. M. J.; Finnegan, C. A.; Mikovits, J.; Ruscetti, F. W.; Blumenthal, R.
  3. Aids. 2004 18(6): 849-858.
  1. 11.   Action of Anti-HIV drugs and resistance: Reverse transcriptase inhibitors and protease inhibitors
  2. Imamichi, T.
  3. Current Pharmaceutical Design. 2004 10(32): 4039-4053.
  1. 12.   Virus entry: Molecular mechanisms and biomedical applications
  2. Dimitrov, D. S.
  3. Nature Reviews Microbiology. 2004 2(2): 109-122.
  1. 13.   C-terminal octylation rescues an inactive T20 mutant - Implications for the mechanism of HIV/simian immunodeficiency virus-induced membrane fusion
  2. Peisajovich, S. G.; Gallo, S. A.; Blumenthal, R.; Shai, Y.
  3. Journal of Biological Chemistry. 2003 278(23): 21012-21017.
  1. 14.   Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells
  2. Howard, O. M. Z.; Dong, H. J. F.; Yang, D.; Raben, N.; Nagaraju, K.; Rosen, A.; Casciola-Rosen, L.; Hartlein, M.; Kron, M.; Yiadom, K.; Dwivedi, S.; Plotz, P. H.; Oppenheim, J. J.
  3. Journal of Experimental Medicine. 2002 196(6): 781-791.
  1. 15.   N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates
  2. Chabot, D. J.; Chen, H.; Dimitrov, D. S.; Broder, C. C.
  3. Journal of Virology. 2000 74(9): 4404-4413.
  1. 16.   Influenza virus upregulates CXCR4 expression in CD4(+) cells
  2. Puri, A.; Riley, J. L.; Kim, D.; Ritchey, D. W.; Hug, P.; Jernigan, K.; Rose, P.; Blumenthal, R.; Carroll, R. G.
  3. Aids Research and Human Retroviruses. 2000 16(1): 19-25.
  1. 17.   Constitutive cell surface association between CD4 and CCR5
  2. Xiao, X. D.; Wu, L. J.; Stantchev, T. S.; Feng, Y. R.; Ugolini, S.; Chen, H.; Shen, Z. M.; Riley, J. L.; Broder, C. C.; Sattentau, Q. J.; Dimitrov, D. S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(13): 7496-7501.
  1. 18.   Role of glycosphingolipids in HIV-1 entry: requirement of globotriosylceramide (Gb3) in CD4/CXCR4-dependent fusion
  2. Puri, A.; Hug, P.; Jernigan, K.; Rose, P.; Blumenthal, R.
  3. Bioscience Reports. 1999 19(4): 317-325.
  1. 19.   Spontaneous and Ligand-Induced Trafficking of Cxc-Chemokine Receptor 4
  2. Tarasova, N. I.; Stauber, R. H.; Michejda, C. J.
  3. Journal of Biological Chemistry. 1998 273(26): 15883-15886.
  1. 20.   Chemically Synthesized Sdf-1-Alpha Analogue, N33a, Is a Potent Chemotactic Agent For Cxcr4/Fusin/Lestr-Expressing Human Leukocytes
  2. Ueda, H.; Siani, M. A.; Gong, W. H.; Thompson, D. A.; Brown, G. G.; Wang, J. M.
  3. Journal of Biological Chemistry. 1997 272(40): 24966-24970.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel